Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Pharmacists, hospitals and students warn committee that HB 12 could undermine safety checks on off‑label prescriptions
Summary
Testimony on House Bill 12 drew broad opposition from hospital physicians, pharmacists, pharmacy students and associations who said the bill would limit pharmacists’ professional judgment, conflict with Ohio pharmacy law and billing practice, and risk patient safety; proponents framed the bill as expanding access to off‑label medicines.
Committee members heard extended, often emotional testimony on House Bill 12, which would change the legal treatment of off‑label prescribing and the pharmacist’s role in accepting or refusing prescriptions.
Dr. Adam Mezoff (pediatric gastroenterologist, Dayton Children’s) warned that HB 12 could let a prescriber unfamiliar with a patient override the interdisciplinary team and undermine checks that protect pediatric patients’ safety. He said the bill’s restrictions on changing another provider’s orders outside emergencies could hamper standard hospital workflows and patient safety reviews: “This could include a dentist prescribing cardiac medications for a 3…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
